China Healthcare Sector Report 2017 3rd QuarterAn EMIS Insights Industry Report
EMIS is a Euromoney Institutional Investor plc company Date: February 2018
Available in: English
China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is generated by pharmaceutical sales. The Chinese healthcare market has been growing strongly, focusing on the treatment of chronic diseases such as cancer, diabetes and respiratory conditions. China's current shortage of quality public healthcare services has resulted in rising demand for private medical care. However, private healthcare is underdeveloped and faces difficulties in finding experienced doctors, as many of them are employed by public hospitals under exclusivity clauses.
This report provides a complete and detailed analysis of the healthcare sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
- Understand the key elements at play in the healthcare sector in China
- Access forecasts for growth in the sector
- View key data on healthcare spending and health insurance in China
- Crystallise the forces both driving and restraining this sector in China
- Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
- Gain an understanding of the regulatory environment for the sector in China
- Build a clear picture of trends and issues for sub-sectors (e.g. medical institutions, medical devices and pharmaceuticals).
See below for a complete table of report contents: